Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Cangene signs WinRho distribution agreement for Australia

Sep. 24, 1998

Vertex issued first U.S. patent for IMPDH inhibitors, begins phase II trials of lead inhibitor

Sep. 23, 1998

International team reports discovery of novel immunostimulants

Sep. 21, 1998

MedImmune and Chiron enter agreement on vaccine adjuvant technology

Sep. 21, 1998

Cangene files for German approval of next-generation WinRho product

Sep. 18, 1998

DNA immunization against rabies effectively protects nonhuman primates

Sep. 17, 1998

Aviron's FluMist PLA/ELA deemed nonfilable by FDA; resubmission planned

Sep. 15, 1998

New T-cell kinase inhibitor presented by Abbott at ACS meeting

Sep. 10, 1998

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Licensing opportunity from the NIH: carrier for conjugate vaccines

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...